CPB
30
6
JPM
69
2
AXP
71
2
ORCL
65
-2
SE
61
-4
XRX
44
3
FTI
81
5
BWA
48
2
HON
67
2
SIG
52
3
DTE
56
2
PYPL
54
2
EL
25
4
NAVI
52
5
JWN
48
6
FDX
43
3
PAYX
53
2
HSIC
56
5
BSX
67
-3
LNC
39
3
CPB
30
6
JPM
69
2
AXP
71
2
ORCL
65
-2
SE
61
-4
XRX
44
3
FTI
81
5
BWA
48
2
HON
67
2
SIG
52
3
DTE
56
2
PYPL
54
2
EL
25
4
NAVI
52
5
JWN
48
6
FDX
43
3
PAYX
53
2
HSIC
56
5
BSX
67
-3
LNC
39
3
Financhill
Back

LENZ Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
89

LENZ
LENZ Therapeutics

Last Price:
35.39
Seasonality Move:
-7.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

LENZ Therapeutics Price Quote

$35.39
-0.11 (3.12%)
(Updated: November 23, 2024 at 5:42 AM ET)

LENZ Therapeutics Key Stats

Buy
89
LENZ Therapeutics (LENZ) is a Buy
Day range:
$33.85 - $36.09
52-week range:
$14.42 - $38.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.53%
Volume:
88K
Avg. volume:
164.8K
1-year change:
118.6%
Market cap:
$976.3M
Revenue:
$15M
EPS:
$-5.24

How Much Does LENZ Therapeutics Make?

Data Unavailable

Is LENZ Therapeutics Growing As A Company?

Data Unavailable

LENZ Therapeutics Stock Price Performance

What Is LENZ Therapeutics 52-Week High & Low?

LENZ Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LENZ Therapeutics?

  • How Much Debt Does LENZ Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does LENZ Therapeutics Have?
    Cash and short term investments quarterly total is $217.1M
  • What Is LENZ Therapeutics’s Book Value Per Share?
    Book value per share is 7.83

Is LENZ Therapeutics Cash Flow Positive?

  • What Is LENZ Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.3M
  • What Is LENZ Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $197M
  • What Is LENZ Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$127.4M

LENZ Therapeutics Return On Invested Capital

Data Unavailable

LENZ Therapeutics Earnings Date & Stock Price

LENZ Therapeutics Competitors

  • Who Are LENZ Therapeutics's Competitors?
    Below is a list of companies who compete with LENZ Therapeutics or are related in some way:
    • Oruka Therapeutics Inc (ORKA)
    • PetMed Express Inc (PETS)
    • R1 RCM Inc (RCM)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LENZ Therapeutics Dividend Yield

LENZ Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.35%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 39.29
Upside from Last Price: 10.66%

Major Shareholders

  • How many LENZ shares are owned by institutional investors?
    29.1M LENZ shares are owned by institutional investors
  • How many LENZ shares are owned by insiders?
    242.8K LENZ shares are owned by insiders